Determination of Record Date and Entitlement

AI SummaryClose X

Roquefort Therapeutics plc has confirmed the record date of 30 November 2025 for determining entitlement to new unlisted redeemable non-voting shares, which will carry rights to future commercial benefits from the Company's Midkine Investments portfolio, with the ultimate aim of an in-specie distribution. Further details regarding entitlement ratios and the number of shares to be issued will be announced shortly.

Disclaimer*

UK 100

Latest directors dealings